NCT00502684 - Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Primary Operable Breast Cancer

Interventions

DRUG

Propranolol, etodolac

propranolol 10 mg X 4 /day, starting on day -3 pre-op, for 6 days, till POD 2 Etodolac 400 mg X2/day, starting on day -3 pre-op, for 6 days, till POD 2

Trial Locations (3)

49100

RECRUITING

Rabin Medical Center, Petah Tikva

52621

RECRUITING

Sheba Medical Center, Ramat Gan

76100

RECRUITING

Kaplan Medical Center, Rehovot